Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Ho Y.-F.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 14 筆資料,總共 14 筆
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2010
2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase
Chang W.-L.; Chang C.-S.; Chiang P.-C.; Ho Y.-F.; Liu J.-F.; Chang K.-W.; JIH-HWA GUH
British Journal of Pharmacology
30
25
2013
Ardisianone, a natural benzoquinone, efficiently induces apoptosis in human hormone-refractory prostate cancers through mitochondrial damage stress and survivin downregulation
Yu C.-C.; Wu P.-J.; Hsu J.-L.; Ho Y.-F.; LIH-CHING HSU
; Chang Y.-J.; Chang H.-S.; Chen I.-S.; JIH-HWA GUH
Prostate
25
22
2011
Costunolide induces apoptosis through nuclear calcium2+ overload and DNA damage response in human prostate cancer
Hsu J.-L.; Pan S.-L.; Ho Y.-F.; Hwang T.-L.; FAN-LU KUNG
; JIH-HWA GUH
Journal of Urology
49
46
2012
Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan?
Lin Wu F.-L.; YUNG-MING CHEN
; TAI-SHUAN LAI
; Shen L.-J.; Ho Y.-F.; Lee Y.-T.; Wu M.-S.; SHUEI-LIONG LIN
; KWAN-DUN WU
Nephron - Clinical Practice
12
12
2020
The Effects of Shared Decision Making on Different Renal Replacement Therapy Decisions in Patients with Chronic Kidney Disease
Ho Y.-F.; Chen Y.-C.; Huang C.-C.; WEN-YU HU
; Lin K.-C.; Li I.-C.
Journal of Nursing Research
11
11
2008
Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress
Hsiao C.-J.; Ho Y.-F.; Hsu J.T.-A.; Chang W.-L.; Chen Y.-C.; Shen Y.-C.; Lyu P.-C.; JIH-HWA GUH
Naunyn-Schmiedeberg's Archives of Pharmacology
9
9
2011
Paclitaxel induces apoptosis through activation of nuclear protein kinase C-δ and subsequent activation of Golgi associated Cdk1 in human hormone refractory prostate cancer
Lu P.-H.; Yu C.-C.; Chiang P.-C.; Chen Y.-C.; Ho Y.-F.; FAN-LU KUNG
; JIH-HWA GUH
Journal of Urology
16
14
2011
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG
; KUN-HUEI YEH
Anti-Cancer Drugs
4
3
2012
Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair
Hsu J.-L.; Leong P.-K.; Ho Y.-F.; LIH-CHING HSU
; Lu P.-H.; Chen C.-S.; JIH-HWA GUH
Cancer Letters
23
17
2022
Pneumococcal conjugate vaccines in Taiwan: optimizing health gains in children and older adults through constrained optimization modeling: Pneumococcal conjugate vaccines optimization in Taiwan
CHUN-YI LU
; Tang C.H.; Fu T.; Pwu R.-F.; Ho Y.-F.
International Journal of Infectious Diseases
0
1
2007
Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways
Chen Y.-C.; Lu P.-H.; Pan S.-L.; Teng C.-M.; Kuo S.-C.; Lin T.-P.; Ho Y.-F.; Huang Y.-C.; JIH-HWA GUH
Biochemical Pharmacology
58
59
2012
Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway
Hsu J.-L.; Ho Y.-F.; TSAI-KUN LI
; Chen C.-S.; LIH-CHING HSU
; JIH-HWA GUH
Biochemical Pharmacology
18
16
2014
Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation
Wang W.-T.; Chen Y.-H.; Hsu J.-L.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Ho Y.-F.; LIH-CHING HSU
; JIH-HWA GUH
Naunyn-Schmiedeberg's Archives of Pharmacology
27
25
2014
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
Hsu J.-L.; SHIH-PING LIU
; Lee C.-C.; LIH-CHING HSU
; Ho Y.-F.; Huang H.-S.; JIH-HWA GUH
Naunyn-Schmiedeberg's Archives of Pharmacology
13
12